Central Pharmaceuticals Ltd. (DSE:CENTRALPHL)

Market Cap	1.39B
Revenue (ttm)	7.02M
Net Income (ttm)	-36.36M
Shares Out	119.80M
EPS (ttm)	-0.30
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,755,857
Average Volume	921,167
Open	n/a
Previous Close	11.20
Day's Range	11.30 - 12.00
52-Week Range	7.50 - 22.50
Beta	0.41
RSI	67.61
Earnings Date	Nov 4, 2025

About Central Pharmaceuticals

Central Pharmaceuticals Ltd. manufactures, markets, and distributes generic human pharmaceutical products in Bangladesh. It offers tablet, capsule, liquid, and ointment. The company offers its products in various therapeutic areas, including antibacterial, antiulcerant, NSAIDs, analgesics and antipyretic, antihistamines, antifungal, vitamins, antihyperglycemic, anti-diabetic, analgesics and antipyretic NSAIDs, antibacterial preparations, antidopaminergic, antihistamines, and other products. Central Pharmaceuticals Ltd. was incorporated in 1980 ...

• Industry: Pharmaceutical Preparations
• Founded: 1980
• Employees: 74
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: CENTRALPHL

Financial Performance

In 2024, Central Pharmaceuticals's revenue was 29.60 million, an increase of 0.93% compared to the previous year's 29.33 million. Losses were -42.42 million, -3.49% less than in 2023.